TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/24 16:03 | 2/9/24 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Li Dean Y | NJ | O | EVP,P,MR | M.d | 913 | 62.07 | 0 | 15 | 47 | 46 | D | ||||||||||||||
2/12/24 16:03 | 2/9/24 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Li Dean Y | NJ | O | EVP,P,MR | S.d | -1,845 | 125.50 | 0 | -15 | -24 | 46 | D | ||||||||||||||
1/11/24 18:51 | 1/9/24 | RXRX | Recursion Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Li Dean Y | UT | D | S | -396 | 13.66 | 0 | -29 | -1 | 3,171 | I | |||||||||||||||
5/3/23 16:10 | 5/1/23 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Li Dean Y | NJ | O | EVP,P,MR | M.d | 123 | 115.47 | 0 | 1 | 5 | 20 | D | ||||||||||||||
5/4/22 17:50 | 5/3/22 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Li Dean Y | NJ | O | EVP,P,MR | M.d | 68 | 87.65 | 0 | 1 | 5 | 16 | D | ||||||||||||||
5/3/22 16:21 | 5/1/22 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Li Dean Y | NJ | O | EVP,P,MR | M.d | 94 | 88.69 | 0 | 1 | 7 | 16 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |